argemone_mexicana_l
Unterschiede
Hier werden die Unterschiede zwischen zwei Versionen angezeigt.
Nächste Überarbeitung | Vorhergehende Überarbeitung | ||
argemone_mexicana_l [2014/09/11 17:06] – angelegt andreas | argemone_mexicana_l [2015/10/23 07:06] (aktuell) – andreas | ||
---|---|---|---|
Zeile 1: | Zeile 1: | ||
- | Argemone mexicana L. - Papaveraceae | + | Argemone mexicana L. - Papaveraceae |
- | prickly poppy, Mexican poppy, **Mexikanischer Stachelmohn**, | + | |
Annual herb to 1m high, native to central America, cultivated for centuries, naturalized in many tropical | Annual herb to 1m high, native to central America, cultivated for centuries, naturalized in many tropical | ||
and subtropical regions; plant with bright yellow latex; stems, leaves and sepals spiny; leaves usually blotched with paler green; flowers closely subtended by the upper leaves, yellow or cream, 3-6 cm wide. | and subtropical regions; plant with bright yellow latex; stems, leaves and sepals spiny; leaves usually blotched with paler green; flowers closely subtended by the upper leaves, yellow or cream, 3-6 cm wide. | ||
+ | |||
+ | "A single sample of authenticated A. mexicana seed contained dihydrosanguinarine as the major alkaloid with minor amounts of sanguinarine and berberine, in agreement with earlier studies. Dihydrosanguinarine and dihydrochelerythrine were measured as their oxidized products, sanguinarine and chelerythrine, | ||
+ | [Isoquinoline alkaloids and keto-fatty acids of Argemone ochroleuca and A. mexicana (mexican poppy) seed. I. An assay method and factors affecting their concentration. Fletcher, M. T., Takken, G., Blaney, B. J., & Alberts, V., Crop and Pasture Science, Vol.44(2), 1993, 265-275] | ||
+ | |||
+ | " | ||
+ | [Clinicoepidemiological, | ||
" | " | ||
Zeile 11: | Zeile 16: | ||
[Quaternary Alkaloids of //Argemone mexicana//. Singh, S.; Singh, T. D.; Singh, V. P.; Pandey, V. B., Pharmaceutical Biology, Vol.48(2), 2010, 158–160] | [Quaternary Alkaloids of //Argemone mexicana//. Singh, S.; Singh, T. D.; Singh, V. P.; Pandey, V. B., Pharmaceutical Biology, Vol.48(2), 2010, 158–160] | ||
- | {{http:// | + | "A prospective, |
+ | [Argemone mexicana decoction for the treatment of uncomplicated falciparum malaria. Willcox, M. L., Graz, B., Falquet, J., Sidibé, O., Forster, M., Diallo, D., Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol.101(12), | ||
+ | |||
+ | "We tested the malaria treatment Argemone mexicana decoction (AM), a validated self-prepared traditional medicine made with one widely available plant and safe across wide dose variations. In an attempt to reflect the real situation in the home-based management of malaria in a remote Malian village, 301 patients with presumed uncomplicated malaria (median age 5 years) were randomly assigned to receive AM or artesunate-amodiaquine [artemisinin combination therapy (ACT)] as first-line treatment. Both treatments were well tolerated. Over 28 days, second-line treatment was not required for 89% (95% CI 84.1-93.2) of patients on AM, versus 95% (95% CI 88.8-98.3) on ACT. Deterioration to severe malaria was 1.9% in both groups in children aged </=5 years (there were no cases in patients aged >5 years) and 0% had coma/convulsions. AM, now government-approved in Mali, could be tested as a first-line complement to standard modern drugs in high-transmission areas, in order to reduce the drug pressure for development of resistance to ACT, in the management of malaria. In view of the low rate of severe malaria and good tolerability, | ||
+ | [Argemone mexicana decoction versus artesunate-amodiaquine for the management of malaria in Mali: policy and public-health implications. Graz, B., Willcox, M. L., Diakite, C., Falquet, J., Dackuo, F., Sidibe, O., Diallo, D., Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol.104(1), 2010, 33] | ||
+ | |||
+ | {{: | ||
+ | Millspaugh, | ||
+ | [[http:// |
argemone_mexicana_l.1410455163.txt.gz · Zuletzt geändert: 2014/09/11 17:06 von andreas